NCT04632810

Brief Summary

Lipedema is a female progressive fat disorder, characterized by a symmetrical increase in subcutaneous adipose tissue in the lower extremities with the exception of the waist. The condition is often misdiagnosed and underdiagnosed. The etiology is poorly understood. Affects about 11% of all women and may lead to pain and immobility. The pathophysiology may be related to sex hormones and inflammatory response. Lipedema fat has been reported not to respond to lifestyle changes or bariatric surgery, both in terms of weight loss and symptom reduction; including pain and quality of life. Clinical research on the effect of dietary interventions on lipedema does not exist, but a pilot study with a ketogenic diet showed a significant reduction in pain regardless of weight loss. The aim of the research project will be to investigate whether a ketogenic diet can be a treatment option for patients with lipedema. Therefore, a randomized controlled trial will be conducted to compare the effects of two diets. 1) energy-restricted ketogenic diet and 3) energy-restricted low-fat non-ketogenic diet for 8 weeks. Pain and quality of life will be mesured at start and immediately after the intervention. The hypothesis is that a ketogenic diet may reduce pain and improve quality of life.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 17, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

March 22, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

2.3 years

First QC Date

November 12, 2020

Last Update Submit

March 12, 2025

Conditions

Keywords

Diet therapyKetosisPainWeight loss

Outcome Measures

Primary Outcomes (2)

  • change in pain intensity

    A difference in mean pain score of 2 units on a continuous scale from 0 to 10 on a visual analog scale (VAS) is considered clinically interesting

    8 weeks

  • change in quality of life

    Likert Scale

    8 weeks

Study Arms (2)

Ketogenic low energy diet

EXPERIMENTAL

Ketogenic low energy diet for 8 weeks

Other: Ketogenic low energy diet

non-Ketogenic low energy diet

ACTIVE COMPARATOR

non-Ketogenic low energy diet for 8 weeks

Other: non-ketogenic low energy diet

Interventions

Participants will follow a low energy diet, with 1200 kcal per day. Carbohydrates 75g (25E%), protein 60 g (20E%), fat 73 g (55E%) in 8 weeks

Ketogenic low energy diet

Participants will follow a low energy diet, with 1200 kcal per day. Carbohydrates 180g (60E%), protein 60 g (20E%), fat 27 g (20E%), in 8 weeks

non-Ketogenic low energy diet

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with lipedema by skilled physical therapists
  • Body mass index \> 30kg/m2 and \< 45kg/m2
  • Stable weight over the last three months (+2-3kg)
  • Not currently dieting to lose weight
  • Willing to meet for follow-ups every second week during the intervention
  • Willing to sign an informed consent before entering the study

You may not qualify if:

  • Pregnant or breast feeding
  • History of infectious diseases
  • Medication known to affect obesity
  • Enrolled in any other obesity treatment
  • Having had bariatric surgery.
  • Kidney disease is excluded
  • History of psychological disorders
  • Not mastering a Scandinavian language
  • Being mentally disabled
  • Malign disease
  • Diabetes
  • Any disease that leads to dietary advice that is not consistent with intervention advice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Levanger Hospital, Nord-Trøndelag Hospital Trust

Levanger, Norway

Location

St Olavs Hospital

Trondheim, Norway

Location

Related Publications (3)

  • Lundanes J, Nes VF, Aakervik O, Ryan L, Hansson P, Rokstad AM, Martins C, Nymo S. Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema. Curr Dev Nutr. 2025 Feb 20;9(3):104571. doi: 10.1016/j.cdnut.2025.104571. eCollection 2025 Mar.

  • Lundanes J, Garseth M, Taylor S, Crescenzi R, Pridmore M, Wagnild R, Hyldmo AA, Martins C, Nymo S. The effect of a low-carbohydrate diet on subcutaneous adipose tissue in females with lipedema. Front Nutr. 2024 Nov 7;11:1484612. doi: 10.3389/fnut.2024.1484612. eCollection 2024.

  • Lundanes J, Storlilokken GE, Solem MS, Dankel SN, Tangvik RJ, Odegard R, Holst JJ, Rehfeld JF, Martins C, Nymo S. Gastrointestinal hormones and subjective ratings of appetite after low-carbohydrate vs low-fat low-energy diets in females with lipedema - A randomized controlled trial. Clin Nutr ESPEN. 2025 Feb;65:16-24. doi: 10.1016/j.clnesp.2024.11.018. Epub 2024 Nov 19.

MeSH Terms

Conditions

LipedemaKetosisPainWeight Loss

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesBody Weight

Study Officials

  • Siren Nymo, PhD

    Nord-Trøndelag Hospital Trust, Namsos Hospital, Clinic of Surgery

    PRINCIPAL INVESTIGATOR
  • Hallvard Græslie, md

    Nord-Trøndelag Hospital Trust, Namsos Hospital, Clinic of Surgery

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2020

First Posted

November 17, 2020

Study Start

March 22, 2021

Primary Completion

July 1, 2023

Study Completion

April 1, 2025

Last Updated

March 13, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations